In 2025, pharma counterfeit analytics shifted from reactive incident tracking to a predictive, data-driven risk management system across the supply chain. By 2026, it becomes a strategic verification hub where AI and technologies like “digital DNA” are essential to protecting patient safety, margins, and regulatory trust.

In 2025, pharma counterfeit analytics shifted from reactive incident tracking to a predictive, data-driven risk management system across the supply chain. By 2026, it becomes a strategic verification hub where AI and technologies like “digital DNA” are essential to protecting patient safety, margins, and regulatory trust.

Product Authentication raises the threshold drastically for counterfeiters.